Absci appoints professor sir mene pangalos to its board of directors

Vancouver, wash., jan. 10, 2024 (globe newswire) -- absci (nasdaq: absi), a generative ai drug creation company, today announced the appointment of seasoned r&d executive professor sir menelas “mene” pangalos to its board of directors and as co-chair of absci's scientific advisory board. sir pangalos was the executive vice president of biopharmaceuticals r&d at astrazeneca. he joins absci as the company scales its ai-enabled portfolio of partnered and wholly-owned assets.
ABSI Ratings Summary
ABSI Quant Ranking